Related Experiment Video
Updated: Sep 6, 2025
08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
6.5K
Immune-Mediated Neonatal Thrombocytopenia
Emily Batton1, Sandra L Leibel1
1Division of Neonatology, Department of Pediatrics, University of California San Diego-Rady Children's Hospital, San Diego, CA.
Neoreviews
|June 30, 2022
Summary
Neonatal immune thrombocytopenia, caused by maternal antibodies crossing the placenta, poses risks. Treatments like IV immune globulin and steroids may help manage these conditions in mothers and newborns.
Area of Science:
- Perinatology
- Immunology
- Neonatology
Background:
- Immune-mediated thrombocytopenia in neonates arises from maternal antiplatelet antibodies crossing the placenta.
- Key causes include neonatal alloimmune thrombocytopenia (NAIT) and autoimmune thrombocytopenia (AIT).
- NAIT presents significant thrombocytopenia and intracranial hemorrhage risk, while AIT is typically milder.
Purpose of the Study:
- To review current literature on immune-mediated thrombocytopenia in pregnant women and neonates.
- To discuss existing management strategies for these conditions.
- To highlight the lack of specific prenatal management guidelines.
Main Methods:
- Literature review of immune-mediated thrombocytopenia in pregnancy and neonates.
- Analysis of management strategies for maternal and neonatal care.
- Discussion of therapeutic options including intravenous immune globulin and systemic steroids.
Main Results:
- Immune-mediated thrombocytopenia is a significant concern in neonates due to transplacental antibody transfer.
- Intravenous immune globulin and systemic steroids show utility in managing at-risk pregnancies for both NAIT and AIT.
- Current literature indicates a need for established prenatal management guidelines.
Conclusions:
- Prenatal management of immune-mediated thrombocytopenia requires further guideline development.
- Intravenous immune globulin and systemic steroids are valuable therapeutic options for affected pregnancies.
- Comprehensive review and discussion of management strategies are crucial for maternal and neonatal outcomes.
Related Concept Videos
01:22Development of Immunocompetence
444
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
444
01:15Transcytosis of IgG
2.9K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.9K
01:25Immunodeficiency Diseases
1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.2K
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K